Exophiala (Wangiella) dermatitidis and cystic fibrosis - Prevalence and risk factors

被引:36
作者
Lebecque, Patrick [1 ]
Leonard, Anissa [1 ]
Huang, Daniel [1 ]
Reychler, Gregory [1 ]
Boeras, Anca [1 ]
Leal, Teresinha [1 ]
Symoens, Francoise [2 ]
机构
[1] Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[2] Sci Inst Publ Hlth, Brussels, Belgium
关键词
PSEUDOMONAS-AERUGINOSA; ADULT PATIENTS; FUNGAL GROWTH; BLACK YEAST; SPUTUM; IDENTIFICATION; INFECTION; CONSENSUS;
D O I
10.3109/13693786.2010.495731
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of this prospective study was to assess the prevalence of Exophiala dermatitidis in respiratory secretions of patients with cystic fibrosis (CF) and to identify risk factors for its presence. The results of all cultures performed over a 2-year period in non lung-transplant patients in our CF clinic were included in the study. Samples consisted of sputum (whenever possible) or deep pharyngeal aspirate after a session of physiotherapy. Specimens were inoculated onto Sabouraud gentamicin-chloramphenicol agar (SGCA) medium (Becton-Dickinson) and incubated at 35 degrees C for 2 days and then at ambient temperature (15-25 degrees C) for 3 weeks. The whole study group included 154 patients (mean age +/- SD: 18.5 y +/- 11.69). E. dermatitidis was isolated from 58 specimens (2.8%) of nine patients (5.8%) out of total of 2065 cultures prepared during the study period. All E. dermatitidis culture-positive patients were pancreatic insufficient and >= 12 y of age. Almost all (8/9) were homozygous for the F508 del mutation. Aspergillus fumigatus colonization and genotype seemed to be predisposing factors. No other significant characteristic was identified in this group, either in terms of predominant bacterial pathogen or treatment. A distinct comparative study performed over 3 months in our laboratory revealed that the use of SGCA yielded identical isolation rates of E. dermatitidis as erythritol-chloramphenicol agar (ECA).</.
引用
收藏
页码:S4 / S9
页数:6
相关论文
共 30 条
[11]   Spirometric reference values from a sample of the general US population [J].
Hankinson, JL ;
Odencrantz, JR ;
Fedan, KB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :179-187
[12]   Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis -: A prospective study [J].
Horré, R ;
Schaal, KP ;
Siekmeier, R ;
Sterzik, B ;
de Hoog, GS ;
Schnitzler, N .
RESPIRATION, 2004, 71 (04) :360-366
[13]   INHIBITION OF FUNGAL GROWTH BY PSEUDOMONAS-AERUGINOSA AND PSEUDOMONAS-CEPACIA ISOLATED FROM PATIENTS WITH CYSTIC-FIBROSIS [J].
KERR, J .
JOURNAL OF INFECTION, 1994, 28 (03) :305-310
[14]   Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth [J].
Kerr, JR ;
Taylor, GW ;
Rutman, A ;
Hoiby, N ;
Cole, PJ ;
Wilson, R .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (05) :385-387
[15]  
Koch C, 2001, PEDIATR PULM, V31, P1, DOI 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO
[16]  
2-T
[17]   EXOPHIALA-DERMATITIDIS PNEUMONIA IN CYSTIC-FIBROSIS [J].
KUSENBACH, G ;
SKOPNIK, H ;
HAASE, G ;
FRIEDRICHS, F ;
DOHMEN, H .
EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (05) :344-346
[18]   A specific database for providing local and national level of integration of clinical data in cystic fibrosis [J].
Leal, T. ;
Reychler, G. ;
Mailleux, P. ;
Gigi, J. ;
Godding, V. ;
Lebecque, P. .
JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (03) :187-193
[19]   Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions [J].
Leaw, SN ;
Chang, HC ;
Sun, HF ;
Barton, R ;
Bouchara, JP ;
Chang, TC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :693-699
[20]   Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis [J].
Lebecque, Patrick ;
Leal, Teresinha ;
Zylberberg, Katia ;
Reychler, Gregory ;
Bossuyt, Xavier ;
Godding, Veronique .
JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) :237-244